Results 231 to 240 of about 1,275,927 (291)

Refractory pneumonia due to persistent SARS-CoV-2 infection in an immunocompromised host successfully treated with extended course nirmatrelvir/ritonavir. [PDF]

ASM Case Rep
Sonoda S, Shimada S, Sawada A, Yasuda T, Shirai T, Furusawa H, Tanaka Y, Tanimoto K, Takeuchi H, Miyazaki Y.   +9 more
europepmc   +1 more source

The imbalance of circulating PD-L1-expressing non-classical/ classical monocytes is involved in immunocompromised host related pulmonary opportunistic infection. [PDF]

Innate Immun
Zhou D, Jin Y, Jin Y, Shen Y, Qu Q, Chen C.   +5 more
europepmc   +1 more source

Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency. [PDF]

Ann Intern Med Clin Cases
Zarowin D, Coe J, Bressman M, Riska P, Yune P, Halaseh G, Akiyama MJ.   +6 more
europepmc   +1 more source

Letter to the Editor Regarding “Impact of COVID‐19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase”

Cancer Medicine, Volume 15, Issue 10, October 2026.
Maria Mazzitelli, Pierluigi Del Vecchio, Jon Salmanton‐García, Antonella Cingolani, Livio Pagano, Carlo Torti   +5 more
wiley   +1 more source

Infections of the immunocompromised host pathogenesis, prevention and therapy ; proceedings of the First International Symposium on Infections of the Immunocompromised Host held in Veldhoven,the Netherlands, 1 - 5 June, 1980

, 1980
Verhoef, Jan, International Symposium on Infections in the Immunocompromised Host 1980 Veldhoven   +1 more
core  

Extensive Intra-host evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host

Guerra-Assunção JA, McErlean R, Townsend K, Flaxl LM, Tian SJ, Swadling L, Breuer J, Lowe DM.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pneumonia in the Immunocompromised Host

Seminars in Roentgenology, 2022
Pneumonia in the immunocompromised host can be devastating and can result from both common and opportunistic organisms. This paper examines the imaging findings in mostly opportunistic organisms which cause pneumonia in the immunocompromised host. Some organisms, such as tuberculosis, non-tuberculous mycobacteria, and influenza will also be discussed ...
Sowmiya, Murali, Aaron, Marks, Allen, Heeger, Farouk, Dako, Jennifer, Febbo   +4 more
openaire   +2 more sources

Is phage therapy acceptable in the immunocompromised host? [PDF]

International Journal of Infectious Diseases, 2008
SummaryOver the last decade, bacteriophages (bacterial viruses) have emerged as the major alternative to antibiotics in the treatment of antibiotic-resistant infections. While a considerable body of evidence has accumulated for the efficacy and safety of
Jan Borysowski, Andrzej Górski
exaly   +2 more sources

The Immunocompromised Host

Dermatologic Clinics, 1989
Infection still remains the most common immediate cause of death in the immunocompromised host. Because of the decreased host defenses leading not only to an increased susceptibility to a variety of opportunistic pathogens (in particular the fungi) but also to a decreased host inflammatory response and resultant clinical findings, infections in these ...
  +5 more sources

Sporotrichosis In Immunocompromised Hosts [PDF]

Journal of Fungi (Basel, Switzerland), 2019
Sporotrichosis is a global implantation or subcutaneous mycosis caused by several members of the genus Sporothrix, a thermo-dimorphic fungus. This disease may also depict an endemic profile, especially in tropical to subtropical zones around the world.
Renata Buccheri, Gil Benard
exaly   +4 more sources